Pharmacokinetics

 Pharmacokinetics 

Whatever the actual mechanism of action of a drug may be, we will want to know: Does the drug actually reach its site of action, and for how long does it stay there? This is governed by three factors:

 

1.  Absorption: Uptake of the drug from the compartment of application into the blood

 

2.  Distribution: Transport / equilibration between the blood and the rest of the organism

 

3.  Elimination: Filtration and secretion in the kidneys; chemical modification in the liver

 

Broadly speaking, absorption and distribution determine the whether a drug will be available at its target site at all, while elimination determines for how long the drug effect will last. The issues of drug absorption, distribution and elimination are collectively referred to as `pharmacoki-netics'.

Comments

Post a Comment

Popular posts from this blog

Strategies of drug development

Image
  Strategies of drug development   Drug development strategies may be classified as follows:   1.    Rational design   2.    Brute force   3.    Traditional medicine / natural products   4.    Mere chance.   Note that these distinctions are not really sharp in practice. E.g., the development of H 2 -receptor blockers described above would be a mixture of strategies 1 and 2. In reality, one will always try to rationally make use of as much infor-mation as possible and then play some kind of lottery to do the rest.   An example of the rational approach to drug design is pro-vided by the development of HIV (human immune defi-ciency virus) protease inhibitors. HIV protease cleaves vi-ral polyproteins – the initial products of translation – into the individual protein components and thus is essential for the maturation of virus particles. The crystal structure of HIV protease was used to design synthetic molecules that would snugly fit into the active site. Figure 1.11 shows the inhibitor s
Read more

Trichomoniasis

  Trichomoniasis   Trichomoniasis is an infection of the lower genital trait in men and women and is caused by an anearobic, motile protozoan trichoman vaginalis. It is categorized as a sexually transmitted disease (STD) with its transmission felt to be principally by direct intimate contact.   Trichomoniasis vaginalis is significant because of the sever vaginitis and its common association with other sexually transmitted infections, particularly Neisseria gonorrhea and Chlamydia trachomatis. Risk Factor   Studies have indicates that there are multiple risk factors for trichomoniasis   Includes   ·          low socio economic status   ·          lack of education   ·          crowded living conditions   ·          lack of sanitation   ·          and poor personal hygiene     However, the principal risk factors, which overides all others, is multiple sexual partners, as is true for most other STDs.   Signs and Symptoms   Trichomoniasis is a leading cause of vulvovaginitis and occasional
Read more

Magnitude of Maternal Health problem in Ethiopia

  Magnitude of Maternal Health problem in Ethiopia   Maternal mortality is one of the health indicator which shows the burden of disease and death; the greatest differential between developing and developed countries. More than 150 million women become pregnant in developing countries each year and an estimated 500, 000 of them die from pregnancy related causes. Other than their health problems most women in the developing countries lack access to modern health care services and increase the magnitude of death from preventable problems. Lack of access to modern health care services has great impact on increasing maternal death. Most pregnant women do not receive antenatal care; deliver with out the assistance of trained health workers etc. The life time risk of death as a result of pregnancy or child birth is estimated at one in twenty – three for women in Africa, compared to about one in 10,000 for women in Northern Europe 75% of Maternal morbidity and mortality related to pregnancy a
Read more